A Double-Blind, Randomized, Multicenter, Active-Comparative, 12-Week Study to Assess the Efficacy and Safety of the Drug in Conjunction With Another Drug in Korean Patients With Primary Hypercholesterolemia.
Phase of Trial: Phase III
Latest Information Update: 14 Mar 2017
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 17 Dec 2009 Planned patient number (136) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual end date (Oct 2003) added as reported by ClinicalTrials.gov.